JOAN HUGHES: Open Payments
NPI 1891861324 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 23 payments from 8 companies in 2025. Trend: 2023 $381 · 2024 $1,141 · 2025 $681
Food & beverage: $676Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $256 |
| Neurocrine BioSciences, Inc. | 3 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| ABBVIE INC. | 2 | $42 |
| Alkermes, Inc. | 1 | $27 |
| Sage Therapeutics, LLC | 1 | $26 |
| Novo Nordisk Inc | 1 | $14 |
Products named: INVEGA SUSTENNA, INGREZZA, CAPLYTA, VRAYLAR, AUSTEDO XR, UZEDY, INVEGA TRINZA, ARISTADA.
Industry payments across CA — which companies pay providers there.
